In agreement with this study, ATG7 was shown to inhibit EMT in triple-negative breast cancer cells (TNBC) by upregulation of E-cadherin and downregulation of N-cadherin, SMA, and Vimentin. This evidence concerns the gene ATG7 and triple-negative breast carcinoma.